In this issue:
Cost-effectiveness of skin surveillance through a specialised high risk melanoma clinic
Clinical features associated with higher risk of melanoma
Consumer acceptance of patient-performed mobile teledermoscopy
A gene signature to differentiate melanoma from benign nevi
Prognostic impact of lymphovascular invasion in cutaneous melanoma
Factors predictive of outcome after dabrafenib and trametinib treatment
Cessation of targeted therapy after a complete response in BRAF-mutant advanced melanoma
3DCRT vs IMRT after therapeutic groin lymphadenectomy for patients with melanoma
Outcomes in MBM patients treated with SRS and various systemic immunologic and targeted melanoma agents
Psychoeducational intervention to reduce fear of cancer recurrence
Use of complementary and alternative medicine in melanoma patients
Please login below to download this issue (PDF)